Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pulmonary Disease, Chronic Obstructive 1Lymphoma, Follicular 1Carcinoma, Bronchogenic 1

Interventions

Carboplatin 6Pemetrexed 3Paclitaxel 3atezolizumab 2Radiosurgery 2Gemcitabine 2Docetaxel 2Cisplatin 2pembrolizumab 1durvalumab 1cemiplimab 1Vinorelbine 1Tyrosine Kinase Inhibitors 1Radiotherapy 1Platinum Compounds 1Nivolumab 1Mediastinoscopy 1Magnetic Resonance Spectroscopy 1Interleukin-15 1Fluticasone 1Exercise Therapy 1Etoposide 1Dasatinib 1Bronchoscopy 1Blood Specimen Collection 1Bevacizumab 1Afatinib 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Bronchogenic × Fluticasone × Clear all
NCT00407264 2006-12-04

Randomized Trial of Fluticasone in Bronchial Premalignancy

Amsterdam UMC, location VUmc

Phase 2 Completed
90 enrolled

Carcinoma, Bronchogenic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡